Biogen Idec/Elan’s Tysabri will receive an FDA review March 6 & 7 for possible return to market.
C-SPAN may broadcast the 2-day meeting. You can send an email to encourage a yes decision.
Even if C-SPAN chooses not to broadcast for free, you can purchase rights to the commercial webcast for a substantial discount – only $20. That’s less than many pay-per-view programs. You have to apply for the discount by February 28.
See details here.
technorati tags: Tysabri, FDA+approval, MS, multiple_sclerosis
No comments:
Post a Comment